Research map: Inhibition of PGC1β-dependent mitochondrial biogenesis enhances EGFR-targeted therapy in lung cancer

Back to the article

Papers in this map

  1. Activation of apoptosis signalling pathways by reactive oxygen species · Maureen Redza-Dutordoir · 2016 · 3802 citations · Cited by this paper
  2. Mitochondrial activity promotes neutrophil degranulation and endothelial dysfunction in systemic infections · 2026 · Related
  3. Fast gene set enrichment analysis · Gennady Korotkevich · 2016 · 3782 citations · Cited by this paper
  4. Impaired gephyrin G-domain trimerization and phase separation in a patient with developmental epileptic encephalopathy · 2026 · Related
  5. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases · Michael Karin · 1995 · 2459 citations · Cited by this paper
  6. Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity · 2026 · Related
  7. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations · Sneha P. Rath · 2020 · 2114 citations · Cited by this paper
  8. Patient-derived resources for decoding and targeting brain metastases ecosystems · 2026 · Related
  9. Telomere dysfunction induces metabolic and mitochondrial compromise · Ergün Sahin · 2011 · 1329 citations · Cited by this paper
  10. Loss of mitochondrial DNA helicase in retinal macroglia drives neovascular retinopathy · 2026 · Related
  11. Mitochondrial Metabolism as a Target for Cancer Therapy · Karthik Vasan · 2020 · 799 citations · Cited by this paper
  12. CCDC174 deficiency impaired human fertility by affecting the alternative splicing of maternal mRNAs · 2026 · Related
  13. Induction of proto-oncogene JUN/AP-1 by serum and TPA · William W. Lamph · 1988 · 683 citations · Cited by this paper
  14. β-hydroxybutyrate restores social deficits by suppressing HDAC9 in the ACC of Shank3B-deficient mice · 2026 · Related
  15. Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP · Jiandie D. Lin · 2005 · 627 citations · Cited by this paper
  16. Targeted enzymatic therapy for coeliac disease · 2026 · Related
  17. The Allelic Context of the C797S Mutation Acquired upon Treatment with Third-Generation EGFR Inhibitors Impacts Sensitivity to Subsequent Treatment Strategies · Matthew J. Niederst · 2015 · 569 citations · Cited by this paper
  18. Experimental models for intestinal host-microbe interactions · 2026 · Related
  19. New insights into PGC ‐1 coactivators: redefining their role in the regulation of mitochondrial function and beyond · Josep A. Villena · 2014 · 419 citations · Cited by this paper
  20. NETosis associates with human TB lung tissue destruction and disease pathogenesis · 2026 · Related
  21. Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases · Qian Lu · 2024 · 337 citations · Cited by this paper
  22. AP-1 Transcription Factors as Regulators of Immune Responses in Cancer · Vassilios Atsaves · 2019 · 302 citations · Cited by this paper
  23. PGC-1 coactivators in the control of energy metabolism · Chang Liu · 2011 · 209 citations · Cited by this paper
  24. FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3 · Judith Hagenbuchner · 2012 · 190 citations · Cited by this paper
  25. Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment · Puyu Shi · 2016 · 185 citations · Cited by this paper
  26. SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer · Eiki Ichihara · 2017 · 154 citations · Cited by this paper
  27. The potential of activator protein 1 (AP-1) in cancer targeted therapy · Dandan Song · 2023 · 151 citations · Cited by this paper
  28. Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation · Puyu Shi · 2017 · 145 citations · Cited by this paper
  29. Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy · Lan‐Feng Dong · 2020 · 137 citations · Cited by this paper
  30. Accumulation of Fra-1 in ras -Transformed Cells Depends on Both Transcriptional Autoregulation and MEK-Dependent Posttranslational Stabilization · Laura Casalino · 2003 · 115 citations · Cited by this paper
  31. The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications’ door · Francesco Talotta · 2020 · 99 citations · Cited by this paper
  32. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation · Chunni Wang · 2017 · 96 citations · Cited by this paper
  33. The Fra-1/AP-1 Oncoprotein: From the “Undruggable” Transcription Factor to Therapeutic Targeting · Laura Casalino · 2022 · 83 citations · Cited by this paper
  34. Transcriptional Control of the ERBB2 Amplicon by ERRα and PGC-1β Promotes Mammary Gland Tumorigenesis · Geneviève Deblois · 2010 · 81 citations · Cited by this paper
  35. UBE2N Promotes Melanoma Growth via MEK/FRA1/SOX10 Signaling · Anushka Dikshit · 2018 · 76 citations · Cited by this paper
  36. The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition · Zhen Chen · 2021 · 74 citations · Cited by this paper
  37. [26] Nuclear retinoic acid receptors: Cloning, analysis, and function · Magnus Pfahl · 1990 · 74 citations · Cited by this paper
  38. Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib · Lei Zhu · 2021 · 69 citations · Cited by this paper
  39. PGC-1β promotes enterocyte lifespan and tumorigenesis in the intestine · Elena Bellafante · 2014 · 65 citations · Cited by this paper

Source: OpenAlex (CC0)